The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2020

Filed:

Aug. 07, 2015
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Aaron Michael Ring, New Haven, CT (US);

Andrew Kruse, Roslindale, MA (US);

Aashish Manglik, Menlo Park, CA (US);

Irving L. Weissman, Stanford, CA (US);

Roy Louis Maute, San Francisco, CA (US);

Melissa N. McCracken, Mountain View, CA (US);

Sydney Gordon, Stanford, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/47 (2006.01); A61K 38/17 (2006.01); C07K 14/705 (2006.01); A61K 35/17 (2015.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61K 51/08 (2006.01); A61K 51/10 (2006.01); C07K 14/725 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70503 (2013.01); A61K 35/17 (2013.01); A61K 38/1761 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61K 51/08 (2013.01); A61K 51/088 (2013.01); A61K 51/10 (2013.01); C07K 14/4747 (2013.01); C07K 14/7051 (2013.01); C07K 14/70532 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01);
Abstract

High affinity PD-1 mimic polypeptides are provided, which (i) comprise at least one amino acid change relative to a wild-type PD-1 protein; and (ii) have an increased affinity for PD-L1 relative to the wild-type protein. Compositions and methods are provided for modulating the activity of immune cells in a mammal by administering a therapeutic dose of a pharmaceutical composition comprising a high affinity PD-1 mimic polypeptide, which blocks the physiological binding interaction between PD-1 and its ligand PD-L1 and/or PD-L2.


Find Patent Forward Citations

Loading…